Video

Breast Reconstruction Trainee Assessment

Author(s):

In this podcast, Maisam Fazel, FRCS, MS, MB BChir, discusses his research into a checklist for breast cancer surgeons.

Is there a checklist that can be used along with operating room supervision to assess how well a breast cancer surgeon performs a particular procedure?

Maisam Fazel, FRCS, MS, MB BChir, of Imperial College Healthcare NHS Trust in the United Kingdom, believes it is not only desirable but also possible to shift surgical training toward a competency-based approach. His research on developing an assessment tool for latissimus dorsi breast reconstruction (LDBR) surgery was among the top-scoring abstracts at the Miami Breast Cancer Conference.

Fazel adapted the Objective Structured Assessment of Technical Skill tool used in the UK surgical curriculum to LDBR, creating categories specific to the procedure. He then used the tool to assess 15 breast reconstruction trainees, who were divided into 3 groups of 5 trainees each based on 2, 4, and 7 years of postinternship experience, respectively.

The assessment tool “was able to significantly discriminate between trainees of different seniority,” with more experienced trainees performing better than those with less seniority.

In this podcast, Fazel discusses his research.

Related Videos
Albert Grinshpun, MD, MSc, head, Breast Oncology Service, Shaare Zedek Medical Center
Erica L. Mayer, MD, MPH, director, clinical research, Dana-Farber Cancer Institute; associate professor, medicine, Harvard Medical School
Stephanie Graff, MD, and Chandler Park, FACP
Mariya Rozenblit, MD, assistant professor, medicine (medical oncology), Yale School of Medicine
Maxwell Lloyd, MD, clinical fellow, medicine, Department of Medicine, Beth Israel Deaconess Medical Center
Neil Iyengar, MD, and Chandler Park, MD, FACP
Azka Ali, MD, medical oncologist, Cleveland Clinic Taussig Cancer Institute
Rena Callahan, MD, and Chandler Park, MD, FACP
Hope S. Rugo, MD, FASCO, Winterhof Family Endowed Professor in Breast Cancer, professor, Department of Medicine (Hematology/Oncology), director, Breast Oncology and Clinical Trials Education; medical director, Cancer Infusion Services; the University of California San Francisco Helen Diller Family Comprehensive Cancer Center
Virginia Kaklamani, MD, DSc, professor, medicine, Division of Hematology-Medical Oncology, The University of Texas (UT) Health Science Center San Antonio; leader, breast cancer program, Mays Cancer Center, UT Health San Antonio MD Anderson Cancer Center